These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27358126)

  • 21. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race.
    Kerschan-Schindl K; Thalmann MM; Weiss E; Tsironi M; Föger-Samwald U; Meinhart J; Skenderi K; Pietschmann P
    PLoS One; 2015; 10(7):e0132478. PubMed ID: 26147574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities.
    Li X; Yang J; Bao M; Zeng K; Fu S; Wang C; Ye L
    Life Sci; 2018 Sep; 208():33-45. PubMed ID: 29969609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment.
    Ueland T; Olarescu NC; Jørgensen AP; Otterdal K; Aukrust P; Godang K; Lekva T; Bollerslev J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):736-43. PubMed ID: 25459913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
    de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerostin and Dkk-1 in patients with ankylosing spondylitis.
    Ustun N; Tok F; Kalyoncu U; Motor S; Yuksel R; Yagiz AE; Guler H; Turhanoglu AD
    Acta Reumatol Port; 2014; 39(2):146-51. PubMed ID: 25111416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Serum Dkk-1, Tenascin-C, Oxidative Stress Markers Levels and Wnt Signaling Pathway Genes Expression in Patients with Alzheimer's Disease.
    Hasanzadeh Z; Nourazarian A; Nikanfar M; Laghousi D; Vatankhah AM; Sadrirad S
    J Mol Neurosci; 2021 Apr; 71(4):879-887. PubMed ID: 32935274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone metastases in gastric cancer follow a RANKL-independent mechanism.
    D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; De Giuli M; Sandrucci S; Ferracini R; Roato I
    Oncol Rep; 2013 Apr; 29(4):1453-8. PubMed ID: 23404437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical parameters of bone metabolism in bone metastases of solid tumors (review).
    Meijer WG; van der Veer E; Willemse PH
    Oncol Rep; 1998; 5(1):5-21. PubMed ID: 9458286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover.
    Yavropoulou MP; van Lierop AH; Hamdy NA; Rizzoli R; Papapoulos SE
    Bone; 2012 Jul; 51(1):153-7. PubMed ID: 22579776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerostin and DKK1 in primary hyperparathyroidism.
    Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
    Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of Sclerostin and Dickkopf-1 levels in patients with fluorine bone injury.
    Wang W; Xu J; Liu K; Liu X; Li C; Cui C; Zhang Y; Li H
    Environ Toxicol Pharmacol; 2013 May; 35(3):402-7. PubMed ID: 23467116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status.
    Dovjak P; Dorfer S; Föger-Samwald U; Kudlacek S; Marculescu R; Pietschmann P
    Gerontology; 2014; 60(6):493-501. PubMed ID: 24943689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.
    Corrado A; Neve A; Macchiarola A; Gaudio A; Marucci A; Cantatore FP
    J Rheumatol; 2013 May; 40(5):684-94. PubMed ID: 23457386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
    Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
    Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the Wnt-β-catenin signalling antagonists, sclerostin and dickkopf-related protein 1, in chronic periodontitis.
    Napimoga MH; Nametala C; da Silva FL; Miranda TS; Bossonaro JP; Demasi AP; Duarte PM
    J Clin Periodontol; 2014 Jun; 41(6):550-7. PubMed ID: 24576302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.
    Hauer K; Calzada-Wack J; Steiger K; Grunewald TG; Baumhoer D; Plehm S; Buch T; Prazeres da Costa O; Esposito I; Burdach S; Richter GH
    Cancer Res; 2013 Jan; 73(2):967-77. PubMed ID: 23204234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.